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I recently attended the 78th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Glasgow and had the pleasure of sitting through a number of excellent sessions describing how pharmacists are being increasingly recognized and utilized as medication experts in health systems around the world. One of the underlying themes of the conference was evidence-how to generate it and how to evaluate it using tools and guidelines that weigh a number of factors, including study design and risk of bias. The advancements in pharmacy practice that we have seen in many countries, including Canada, have been based in large part on well-designed pharmacy practice research that has provided strong evidence of improved patient outcomes, economic benefits or other improvements in health care delivery as a result of changes to the scope of practice for pharmacists. This type of evidence is increasingly being demanded by regulators and policy makers to support not only the approval of new medications but also changes to the way in which health care is delivered and paid for.
The presentations at FIP that focused on the challenges of designing studies to evaluate medications or innovations in pharmacy practice were in sharp contrast to another session at the conference in which the motion that "pharmacists should not sell or dispense homeopathic products" was debated. Although the motion was supported by about twothirds of the audience, it was disappointing that more than 30% of the audience voted against the motion, with many speaking passionately in support of the sale of homeopathic products in pharmacies. It would be easy to attribute this to the international nature of the audience, but data suggest that the numbers in Canada may not be that different. A poll published on the Canadian Healthcare Network website in 2018 indicated that 27% of pharmacists answered no to the question "Would you consider pulling homeopathy products from your shelves?" No legitimate scientist, evidence-based practitioner or health organization supports the use of homeopathy for the treatment of any disease. Unlike some other alternative therapies that have potential, if not well-studied benefits, the basic principles behind homeopathic medicines (like treats like, dilution increases potency, water memory and "potentization" by vigorous shaking) are at odds with well-established scientific principles and common sense. An evaluation of evidence for and against the effectiveness of homeopathy based on the Cochrane Database of Systematic Reviews concluded that the effectiveness of homeopathy is equivalent to placebo. 6 The European Academies Science Advisory Council, an organization that represents 29 scientific organizations in Europe, has stated that "there are no known diseases for which there is robust, reproducible evidence that homeopathy is effective beyond the placebo effect, " 7 a conclusion that is supported by the Center for Complementary and Integrative Health in the United States 8 and the National Health and Medical
Research Council in Australia. 9 Proponents have argued that these medicines are worth a try since they do not have side effects, an observation that is not too surprising given that they typically don't contain an appreciable amount of an active ingredient. As conscientious health care providers, we need to be respectful of the rights of patients to make their own choices regarding how to manage their health and patients have the option of purchasing these products at a number of retail outlets. Although adverse events with the products themselves are uncommon, I would argue that there are important adverse effects for our profession when these products are sold in pharmacies. Our credibility EDITORIAL COMMENTARY as evidence-based practitioners is seriously undermined when we have significant numbers of pharmacists who are willing to recommend or sell homeopathic and other products that have little or no evidence of effectiveness.
In 1996, Sackett et al. 10 provided a definition of evidencebased practice as "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. " This has been the foundation of clinical decision-making and health professional education in Canada and other countries for many years. Much time and effort are spent educating pharmacy students on how to critically appraise the biomedical literature in order to be able to integrate the latest evidence into their clinical practice. This skill is essential to effectively evaluate drug therapy and make patient-specific recommendations for prescription and nonprescription treatment. The requirement to train new pharmacists for evidence-based practice comes from a number of organizations, including those that regulate the practice of pharmacy in Canada. The Association of Faculties of Pharmacy of Canada (AFPC) lists the ability to "integrate best available evidence into pharmacy practice" as an expected outcome that graduating pharmacy students should achieve. 11 A competency for Canadian pharmacists at entry to practice, as stated by the National medicine-conventional and alternative. There is only medicine that has been adequately tested and medicine that has not. " Similarly, we cannot have 2 kinds of pharmacists-those that engage in evidence-based practice and those who choose to make recommendations based on anecdote, testimonial and scientifically implausible theory. As we seek the approval of government, regulators and our fellow health care providers to take a more active role in medication management, is it any wonder that we encounter resistance? When it comes to our future as the recognized expert on medications in the health care system, we must clearly answer the question "Are we evidence-based practitioners or not?" The answer cannot be "sometimes" or "depends on who you talk to" but must be a resounding and unanimous "Yes"! ■
